China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHIFree Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the stock.

China Pharma Price Performance

Shares of CPHI stock opened at $0.20 on Friday. The company has a 50 day moving average price of $0.22 and a 200-day moving average price of $0.23. China Pharma has a 52 week low of $0.17 and a 52 week high of $0.69. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Articles

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.